FDA Inspection 1226962 - The Richline Group Inc - January 12, 2024

FDA Inspection 1226962 for The Richline Group Inc on January 12, 2024. Classification: Official Action Indicated (OAI).

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA Inspection 1226962 for The Richline Group Inc on January 12, 2024. Classification: Official Action Indicated (OAI).

Violation Codes

21 CFR 820.181

21 CFR 820.184

21 CFR 820.20(a)

21 CFR 820.20(b)(3)

21 CFR 820.20(c)

21 CFR 820.22

21 CFR 820.25(b)

21 CFR 820.40(a)

21 CFR 820.50(b)

21 CFR 820.70(e)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

The Richline Group Inc

Inspection Date

January 12, 2024

Product Type

Devices

Office

Center for Devices and Radiological Health

ID: 3bcaf94b-d9d3-4a4c-8331-9b36f32f12ae

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox